Compass Pathways Tech Stack

Clinical-stage biotech developing psilocybin therapy for treatment-resistant depression

Mental Health Care London, England 51–200 employees Founded 2016 Public Company

Compass Pathways is a public biotech company advancing COMP360, an investigational psilocybin-based treatment for treatment-resistant depression and post-traumatic stress disorder. The hiring mix—dominated by senior and director-level roles in healthcare, marketing, and finance—reflects a company transitioning from early-stage development toward regulatory milestone management and commercial preparation. Active projects span regulatory filing, clinical data infrastructure, and commercial analytics, while pain points center on trial data governance and global regulatory compliance readiness.

Tech Stack 12 technologies

Core StackSalesforce Intune SAS Zoom Rooms JAMF Microsoft 365 Windows macOS Microsoft Office Microsoft Planner R CDISC

What Compass Pathways Is Building

◆Challenges

Unmet need in trd
Ensuring compliance with global regulatory requirements
Managing reputation through clinical milestones
Regulatory inspection readiness
Clinical trial data management
Aligning incentive compensation
Data integrity and governance
Predictive accuracy improvement
Resource allocation optimization
Optimizing sales coverage

▲Active Projects

Regulatory filing communications
Global pipeline communications program
Post-traumatic stress disorder development
Treatment-resistant depression development
Risk-based gcp audit program
Business plan development for commercial opex investments
Dashboards and visualization tools
Data models for commercial analytics
Sop development for quality and velocity
Database lock readiness

Hiring Activity

Accelerating20 roles · 15 in 30d

Department

Healthcare

Marketing

Finance

Data

Manufacturing

Communications

Ops

Seniority

Senior

Director

Mid

Manager

Principal

Company intelligence

Find more companies like Compass Pathways by tech stack, pain points and active projects

Get started free

About Compass Pathways

Compass Pathways is a UK-headquartered biotechnology company founded in 2016 and operating as a public entity. The company focuses on advancing evidence-based innovation in mental health through its lead program, COMP360 psilocybin therapy, targeting patients with treatment-resistant depression and related indications. Operations span the United Kingdom, Canada, and the United States. The organization manages clinical development programs, regulatory interactions, and early commercial infrastructure—supported by a tech stack centered on Salesforce, SAS, R, and CDISC-aligned data management tools typical of regulated biotech environments.

HeadquartersLondon, England

Company Size51–200 employees

Founded2016

Hiring MarketsUnited Kingdom, Canada, United States

Frequently Asked Questions

What technology does Compass Pathways use for data management?

Compass Pathways uses SAS, R, and CDISC standards for clinical data modeling and analytics, alongside Salesforce for CRM and Microsoft 365 for core operations. The company is actively building dashboards and data models for commercial analytics.

What programs is Compass Pathways developing?

Compass Pathways' lead program is COMP360 psilocybin therapy for treatment-resistant depression. The company is also advancing a development program for post-traumatic stress disorder. Projects include regulatory filing communications, clinical data management systems, and commercial readiness planning.